These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 14524088

  • 21. [Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].
    Borzenko AS, gagarina SG, Samoĭlova IV, Kalushenina AA.
    Probl Tuberk Bolezn Legk; 2007; (12):28-30. PubMed ID: 18326212
    [Abstract] [Full Text] [Related]

  • 22. Filtrable forms of mycobacteria tuberculosis.
    Khomenko AG, Golyshevskaya VI.
    Z Erkr Atmungsorgane; 1984; 162(2):147-54. PubMed ID: 6429959
    [Abstract] [Full Text] [Related]

  • 23. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV, Vasil'eva IA, Chernousova LN.
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [Abstract] [Full Text] [Related]

  • 24. [Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs].
    Ots ON, Agkatsev TV, Perel'man MI.
    Probl Tuberk Bolezn Legk; 2009; (2):42-9. PubMed ID: 19382642
    [Abstract] [Full Text] [Related]

  • 25. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS.
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [Abstract] [Full Text] [Related]

  • 26. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [Abstract] [Full Text] [Related]

  • 27. [Monitoring of drug resistance in Mycobacterium tuberculosis in the Republic of Sakha (Yakutia)].
    Alekseeva GI, Kravshenko AF.
    Probl Tuberk Bolezn Legk; 2007 Aug; (7):30-3. PubMed ID: 17722289
    [Abstract] [Full Text] [Related]

  • 28. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM, Iarygina IV.
    Probl Tuberk Bolezn Legk; 2007 Aug; (2):17-20. PubMed ID: 17419328
    [Abstract] [Full Text] [Related]

  • 29. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
    Munsiff SS, Li J, Cook SV, Piatek A, Laraque F, Ebrahimzadeh A, Fujiwara PI.
    Clin Infect Dis; 2006 Jun 15; 42(12):1702-10. PubMed ID: 16705575
    [Abstract] [Full Text] [Related]

  • 30. [Acute toxic encephalopathy in patients with tuberculosis].
    Korniliva ZKh, Khokhlov IuK, Savin AA, Batyrov FA.
    Probl Tuberk; 2002 Jun 15; (12):42-6. PubMed ID: 12611336
    [Abstract] [Full Text] [Related]

  • 31. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis].
    Kibrik BS, Zakharov AV.
    Probl Tuberk Bolezn Legk; 2009 Jun 15; (4):23-7. PubMed ID: 19514450
    [Abstract] [Full Text] [Related]

  • 32. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV, Ovsiankina ES.
    Probl Tuberk Bolezn Legk; 2007 Jun 15; (5):20-2. PubMed ID: 17600925
    [Abstract] [Full Text] [Related]

  • 33. [Infiltrative pulmonary tuberculosis: course and efficiency of treatment].
    Mishin VIu, Nazarova NV, Kononen AS, Miakishev TV, Sadovski AI.
    Probl Tuberk Bolezn Legk; 2006 Jun 15; (10):7-12. PubMed ID: 17139824
    [Abstract] [Full Text] [Related]

  • 34. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV, Kornilova ZKh, Alekseeva LP.
    Probl Tuberk Bolezn Legk; 2005 Jun 15; (10):20-8. PubMed ID: 16318255
    [Abstract] [Full Text] [Related]

  • 35. [Combined therapy of pulmonary tuberculosis by using recombinant interleukins].
    Skvortsova LA, Pavlova MV, Vinogradova TI, Archakova LI.
    Probl Tuberk Bolezn Legk; 2003 Jun 15; (10):9-12. PubMed ID: 14669620
    [Abstract] [Full Text] [Related]

  • 36. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].
    Isakova ZhT, Pak OA, Iusupova EIu, Myrzaliev BB, Chubakov TCh, Goncharova ZA, Tumashova AF, Kozhomkulov MD, Kozhomkulov DK, Alisherov ASh, Friedland J, Aldashev AA.
    Probl Tuberk Bolezn Legk; 2005 Jun 15; (8):50-3. PubMed ID: 16209022
    [Abstract] [Full Text] [Related]

  • 37. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV, Erokhin VV, Chernichenko NV, Evgushchenko GV, Lepekha LN, Rozenberg OA.
    Probl Tuberk Bolezn Legk; 2006 Jun 15; (10):12-7. PubMed ID: 17139825
    [Abstract] [Full Text] [Related]

  • 38. [Drug resistance of Mycobacterium tuberculosis of the genotype Beijing in imprisonment places in the Arkhangelsk Region].
    Tungusova OS, Mar'iandyshev AO, Bewne H, Sandwen P.
    Probl Tuberk Bolezn Legk; 2004 Jun 15; (8):35-41. PubMed ID: 15478557
    [Abstract] [Full Text] [Related]

  • 39. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI, Pisarevskaia LI, Nikishina EV.
    Voen Med Zh; 1999 Oct 15; 320(10):65-7, 96. PubMed ID: 10605346
    [Abstract] [Full Text] [Related]

  • 40. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
    Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y.
    Clin Infect Dis; 2007 Jun 01; 44(11):1421-7. PubMed ID: 17479936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.